Aspirin and other anti-inflammatory drugs reduce the risk of skin cancer. Danish researchers compared the painkiller history of more than 18,000 people with skin cancer to that of nearly 180,000 people without the disease. They found that people who had filled at least two prescriptions for aspirin, celecoxib, ibuprofen or naproxen between 1991 and 2002 were less likely to develop either squamous cell carcinoma or the most serious form of skin cancer, melanoma.
Those who took the most of such NSAID pain relievers got the biggest response: a 46 percent lower likelihood of developing melanoma and a 35 percent lower chance of squamous cell carcinoma. This expands the repertoire of cancers that aspirin can help prevent. In addition to skin cancer, people who take aspirin are less likely to develop colorectal, lung, brain, esophageal, kidney, bladder, breast and prostate tumors. NSAIDs do pose a risk and no one should undertake long-term treatment with such drugs without medical supervision.
[Cancer, online, May 29, 2012]

Join Over 54,000 Subscribers at The People's Pharmacy

Each week we send two free email newsletters with breaking health news, prescription drug information, home remedies and a preview of our award-winning radio show. Join our mailing list and get the information you need to make confident choices about your health.

  1. HJL
    Reply

    Fascinating. Does anyone know or have a theory why this is so. Many know that aspirin not only helps the pain of sunburn but minimizes the sunburn itself.
    Is it just the anti-inflammatory effect or something else?
    We know obesity is a cancer risk factor and that obese people often have a high degree of general inflammation often caused by excess sugar consumption.
    Maybe it is as simple as inflammation?

What Do You Think?

Share your thoughts with others, but be mindful of protecting your own and others' privacy. Not all comments will be posted. Advice from web visitors is not a substitute for medical attention. Do not stop any medicine without checking with the prescriber. In posting a comment, you agree to our commenting policy and website terms and conditions.